A preliminary transcriptome map of non-small cell lung cancer

Cancer Research

Volumn 62, Issue 12, 2002, Pages 3340-3346

  Fujii, Takeshi ^a   Dracheva, Tatiana ^a   Player, Audrey ^a   Chacko, Susan ^a   Clifford, Robert ^a   Strausberg, Robert L ^b   Buetow, Kenneth ^a   Azumi, Norio ^c   Travis, William D ^d   Jen, Jin ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^d ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ARTICLE; CHROMOSOME MAP; CONTROLLED STUDY; CYTOGENETICS; DATA BASE; DISEASE ASSOCIATION; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION REGULATION; HETEROZYGOSITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION REGULATION; TRANSCRIPTOME MAP;

CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; LUNG NEOPLASMS; MULTIGENE FAMILY; TRANSCRIPTION, GENETIC;

EID: 0037096897     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Cytogenetic analysis of 63 non-small cell lung carcinomas: Recurrent chromosome alterations amid frequent and widespread genomic upheaval
2. Chromosomal imbalance maps of malignant solid tumors: A cytogenetic survey of 3185 neoplasms
3. Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung
4. Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers
5. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering
6. Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas
7. Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung
8. Comparison of chromosomal imbalances in neuroendocrine and non-small-cell lung carcinomas
9. Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung
10. Genomic imbalances in human lung adenocarcinomas and squamous cell carcinomas
11. Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization
12. Serial analysis of gene expression in non-small cell lung cancer
13. Molecular characteristics of non-small cell lung cancer
14. Genome-wide analysis of DNA copy-number changes using cDNA microarrays
15. The human transcriptome map: Clustering of highly expressed genes in chromosomal domains
16. Initial sequencing and analysis of the human genome
17. The sequence of the human genome
18. Heterogeneity in polyadenylation cleavage sites in mammalian mRNA sequences: Implications for SAGE analysis
19. Gene expression profiles in normal and cancer cells
20. Genetic instabilities in human cancers
21. DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinoma
22. A broad amplification pattern at 3q in squamous cell lung cancer-a fluorescence in situ hybridization study
23. Amplification of 3q26 approximately qter correlates with tumor progression in head and neck squamous cell carcinomas
24. Molecular cytogenetic characterization of head and neck squamous cell carcinoma and refinement of 3q amplification
25. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains
26. SNO is a probable target for gene amplification at 3q26 in squamous-cell carcinomas of the esophagus
27. Molecular definition of a small amplification domain within 3q26 in tumors of cervix, ovary, and lung
28. AIS is an oncogene amplified in squamous cell carcinoma
29. Frequent allelic imbalance suggests involvement of a tumor suppressor gene at p36 in the pathogenesis of human lung cancers
30. Hypermethylation in human cancers of the RIZI tumor suppressor gene, a member of a histone/protein methyltransferase superfamily
31. Loss of heterozygosity is related to p53 mutations and smoking in lung cancer
32. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: Identification and evaluation of the resident candidate tumor suppressor genes
33. Methylation associated inactivation of RASSFIA from region 3p21.3 in lung, breast and ovarian tumors
34. Epigenetic inactivation of RASSFIA in lung and breast cancers and malignant phenotype suppression
35. Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B
36. Overexpression of candidate tumor suppressor gene FUS-isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells
37. Analysis of PTEN/MMAC-alterations in aerodigestive tract tumors
38. Distinct regions of allelic imbalance on chromosome 10q22-q26 in squamous cell carcinomas of the lung
39. Loss of heterozygosity at 10q in tumors of the upper respiratory tract is associated with poor prognosis
40. Detection of functional PTEN lipid phosphatase protein and enzyme activity in squamous cell carcinomas of the head and neck, despite loss of heterozygosity at this locus
41. Expression-based genetic/physical maps of single-nucleotide polymorphisms identified by the cancer genome anatomy project
42. Genomic alterations associated with malignancy in head and neck cancer
43. Deletions of chromosome 4 at multiple sites are frequent in malignant mesothelioma and small cell lung carcinoma
44. Comparative genomic hybridization analysis detects frequent over-representation of DNA sequences at 3q, 7p, and 8q in head and neck carcinomas
45. Comparative genomic hybridization analysis suggests a gain of chromosome 7p associated with lymph node metastasis in non-small cell lung cancer